Navigation Links
New Study Says Purported Melanoma Epidemic is Vastly Overstated
Date:6/22/2009

British Journal of Dermatology study blames physician misdiagnosis as the likely cause of apparent uptick in melanoma cases

WASHINGTON, June 22 /PRNewswire-USNewswire/ -- A newly released study in the June 2009 British Journal of Dermatology that reviews data from a 13-year period in the eastern United Kingdom has concluded that the much-hyped melanoma "epidemic" is unlikely to be real.

The study attributed the increase in melanoma diagnoses to heightened sensitivity and caution on the side of doctors in classifying benign tumors as melanoma. "Dermatologists, pathologists and other medical practitioners have become more cautious in the last two decades, as the consequences of a wrong diagnosis have become more pervasive," the authors wrote in their analysis of the data.

"[T]he present findings make it extremely unlikely that the reported large increase in the incidence of melanoma is real," the authors concluded.

The increase in reported cases was found almost entirely in Stage 1 melanoma, an early stage of the cancer. Patients treated for Stage 1 have the highest survival rate over time as compared to later stages. However, the study found that the overall mortality rate from melanoma only increased slightly over the period.

The study's authors strongly cautioned against creating panic and excessive anxiety about melanoma rates. "Until the necessary research is done, and the true story is established...encouragement of public anxiety about a melanoma epidemic and excessive avoidance of solar exposure for its prevention is unjustifiable."

"For years the Dermatology and sun-scare community -- typically people who are positioned to make a profit by scaring people away from Ultraviolet (UV) light -- have been using increased melanoma rates as 'proof' that people ought to stay out of the sun," said John Overstreet, Executive Director of the Indoor Tanning Association. "However, as this new study illustrates, their sun-abstinence message continues to be without basis. This new information, in addition to all of the new evidence about the health benefits of Vitamin D (the sunshine vitamin), should make people rethink their fear of UV light."

The study's authors also warned that the changes in diagnosis standards have created unnecessary costs on society and individuals. "It may have resulted in unnecessary excisions, health care and insurance costs, let alone the problems and anxieties given to patients and their families," the authors wrote.

To schedule an interview, contact Sarah Longwell at 202.420.7865. To learn more about melanoma scares, go to www.sunlightscam.com. To read the abstract of the British Journal of Dermatology study, visit http://www3.interscience.wiley.com/journal/122453431/abstract.

The Indoor Tanning Association represents thousands of indoor tanning manufacturers, distributors, facility owners and members from other support industries. The ITA promotes a responsible message about moderate tanning and sunburn prevention.


'/>"/>
SOURCE Indoor Tanning Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. VA Launches 10-Year Health Study of 60,000 New Veterans
2. Alterations in brains white matter key to schizophrenia, UCLA study shows
3. Fish protein link to controlling high blood pressure -- new study
4. Redesigned Corporate Identity and nowEDC Software Upgrade Reflect Datatrials Commitment To Stress Free Study Delivery
5. Statins can protect against Alzheimers disease, according to new study
6. Major study highlights weight differences among 3-19 year-olds with type 1 and 2 diabetes
7. Horse Study: RBC Life Sciences Antioxidant, Microhydrin, Reduced Lactic Acid Buildup and Improved Hydration During Strenuous Exercise
8. HealthLeaders-InterStudy Unveils Enhanced Employer Vantage
9. Thomson Reuters Study Finds Baby Boomers and Generation X Face Healthcare Cost Hurdles
10. Study finds cancer is the second most frequent cause of death in individuals with schizophrenia
11. Study finds that tobacco companies changed design of cigarettes without alerting smokers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... Evoke Therapy ... adults, has kicked off its 4th annual Forum for Innovative Treatment Solutions (FITS), ... “Attachment Informed Therapy for Mental Health and Addiction.” , FITS’ 2017 keynote ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... The adage ... Flex House, the next project in the company’s esteemed VISION House demonstration project series. ... use exactly the amount of resources they need to live affordably and abundantly without ...
(Date:4/21/2017)... Arvada, CO (PRWEB) , ... April 21, 2017 ... ... health and performance system, has partnered with O2X , an active lifestyle ... are focused on improving the health of firefighters, police offers, first responders, military ...
(Date:4/21/2017)... CA (PRWEB) , ... April 21, 2017 , ... ... Joseph Health held the much anticipated Regional Primary Care Spring Symposium on April ... in the local medical community, offering physicians and healthcare providers an opportunity to ...
(Date:4/21/2017)... City, UT (PRWEB) , ... April 21, 2017 , ... ... solutions, recently partnered with Advanced Patient Care of Utah (APCUT) and has appointed Rex ... for the next chapter of growth for our agency and our ability to provide ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
(Date:4/18/2017)... Ohio , April 18, 2017  Cardinal Health ... Non-GAAP 1 fiscal 2017 earnings per share (EPS) ... and 2019.  This is in conjunction with this morning,s ... Deep Vein Thrombosis and Nutritional Insufficiency businesses. ... from continuing operations will be at the bottom of ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, 2017 ... ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and Cameron ... announced the signing of a three-year exclusive sales ... deploy a dedicated sales team to introduce Imprimis, ... primarily focused in 13 states in the U.S. ...
Breaking Medicine Technology: